Named as a key player in 1,155 of our reports, across 33 regions and countries.
Our reports that name Siemens Healthineers as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Siemens Healthineers (number of shared markets).
GE Healthcare19 shared markets
Abbott Laboratories15 shared markets
Philips Healthcare14 shared markets
Roche Diagnostics14 shared markets
IBM Watson Health8 shared markets
Medtronic8 shared markets
Thermo Fisher Scientific Inc.8 shared markets
BD (Becton, Dickinson)7 shared markets
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
0 active studies led by Siemens Healthineers, of 14 in all
Source: ClinicalTrials.gov, Studies with Siemens Healthineers (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
9 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Siemens Healthineers leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Siemens Healthineers or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
The topics of the markets Siemens Healthineers is in.
Stories on the topics Siemens Healthineers works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read